A 20-Week Multicenter, Randomized, Double-Blind (DB), Placebo-Controlled, Phase 3 Trial (EPX 100-003) of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in patients with Lennox-Gastaut Syndrome (LGS) (P8-9.007)
Authors
- Scott C. Baraban (ORCID: https://orcid.org/0000-0003-1975-9781)
- George G. Nomikos (ORCID: https://orcid.org/0000-0003-2846-1426)
- Amit Ray (ORCID: https://orcid.org/0000-0001-5576-2086)
- Kumar Budur
- Grant Runyan
- David J. Albers (ORCID: https://orcid.org/0000-0002-5369-526X)
- James H. Philip
Institutions
- University of California, San Francisco (US)